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S U M M A R Y
Background: Granulomatous mastitis (GM) is a chronic inﬂammatory breast lesion. Its etiology remains
incompletely deﬁned. Although mounting evidence suggests the involvement of Corynebacterium in
GM, there has been no systematic study of GM bacteriology using -omics technology.
Methods: The bacterial diversity and relative abundances in breast abscesses from 19 women with GM
were investigated using 16S rDNA metagenomic sequencing and Sanger sequencing. A quantitative PCR
(qPCR) assay was also developed to identify Corynebacterium kroppenstedtii.
Results: A bioinformatic analysis revealed that Corynebacterium was present in the 19 GM patients, with
abundances ranging from 1.1% to 58.9%. Of note, Corynebacterium was the most abundant taxon in seven
patients (more than a third of the subjects). The predominance of Corynebacterium kroppenstedtii
infection (11 of 19 patients, 57.9%) was conﬁrmed with Sanger sequencing and the qPCR assay.
Conclusions: This study proﬁled the microbiota of patients with GM and indicated an important role for
Corynebacterium, and in particular C. kroppenstedtii, in the pathogenesis of this disease.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
Granulomatous mastitis (GM) is a rare chronic inﬂammatory
lesion of the mammary gland that was ﬁrst truly established as an
individual disease by Kessler in 1972.1–3 It is also known as
‘granulomatous lobular mastitis’, and usually affects women of
reproductive age. This entity is characterized by the presence of an
ill-deﬁned mass, galactorrhea, abscess, sinuses, and/or cutaneous
ulceration.4 In clinical practice, its differential diagnosis poses a
problem because it resembles other forms of non-lactating
mastitis, such as periductal mastitis and breast tuberculosis. At
present, the deﬁnitive diagnosis relies on histopathology.
There have been several theories concerning the initial causes
of GM, including inﬂammatory reactions, autoimmunity or* Corresponding author at: Corresponding author. Tel.: +86 20 86531705.
E-mail address: wangqigz@hotmail.com (Q. Wang).
1 Hai-jing Yu and Hua Deng contributed equally to this work.
http://dx.doi.org/10.1016/j.ijid.2016.10.015
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).hypersensitivity, local trauma, breast-feeding, oral contraceptives,
and microbial infection.5–8 However, it remains a subject for
debate, because there is insufﬁcient evidence for a deﬁnitive
conclusion to be drawn. As its etiology is ambiguous, no effective
therapeutic algorithm or clinical management strategy for this
condition has yet been established. Corticosteroids, surgical
excision, and antibiotics have been reported as the ﬁrst line of
treatment.9–11 However, the various protocols or differing
combinations of these strategies often have variable consequences,
including recurrence and unnecessary radical mastectomies.12,13
In recent decades, a growing literature has suggested that
Corynebacterium infection is closely related to the pathogenesis
of GM. Bacterial culture, PCR, and 16S rDNA sequencing have been
used in most of these studies. However, there has been no
systematic study of GM bacteriology, especially with an -omics
approach. Therefore, the microﬂora involved in GM is still
incompletely characterized.
In China, the incidence of chronic non-lactating mastitis,
especially GM, has gradually increased, and it is even moreciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Primer sets and probe used for sequencing and qPCR
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pathogens should contribute to the diagnosis and treatment of
these diseases.
In the present study, the microbiota in breast pus was examined
using metagenomic sequencing and a bioinformatic analysis.
Corynebacterium was found in all 19 patients investigated, with
abundances ranging from 1.1% to 58.9%. In seven patients, the most
abundant taxon was Corynebacterium. More importantly, PCR
sequencing conﬁrmed the predominance of Corynebacterium
kroppenstedtii infection in these subjects (11 of 19 patients,
57.9%). A speciﬁc qPCR assay was developed to quantitatively
assess C. kroppenstedtii. This could be used to guide targeted
therapy in the clinical context. These ﬁndings shed more light on
the role of Corynebacterium in the development of GM and may
facilitate a precise treatment for this disease entity.
2. Methods
2.1. Patients and specimens
This study was approved by the Institutional Ethics Board of
Guangdong Women and Children Hospital; written informed
consent was obtained from all of the participants. In total, 19 women
histologically diagnosed with GM were recruited into the study. The
patients ranged in age from 25 to 36 years, with a mean age of
30.5 years. The clinical symptoms included a breast lump, abscess,
sinus, and/or cutaneous ulceration. Three age-matched women with
acute lactating mastitis were also included in the study as controls.
None of the patients in this series had received antimicrobial
treatment. Specimens from breast core biopsies or surgical excision
were sent for histological examination. The breast pus was aspirated
with a sterile syringe and divided into two samples, one for
metagenomic analysis and the other for bacterial culture.
2.2. Pathological evaluation
Hematoxylin–eosin (HE) staining was performed and sections
of each sample were carefully reviewed by two independent
pathologists. GM is principally characterized by the presence of
non-necrotizing granulomas, conﬁned to the breast lobules. In
detail, the histological features of GM include signs of chronic
granulomatous inﬂammation with clusters of multinucleate giant
cells, leukocytes, epithelioid cells, and macrophages, as well as
abscess.
2.3. Metagenomic analysis
Metagenomic sequencing has been described elsewhere.14–16
In brief, it includes DNA extraction, library preparation, sequenc-
ing, and data processing. DNA was isolated with a TIANamp
Genomic DNA Kit (catalog number DP304-02; TIANGEN Biotech
(Beijing) Co., Ltd., Beijing), according to the manufacturer’s
instructions. The fusion primer set, which incorporated adapter
sequences, indexing barcodes, and PCR primers (515F:
GTGCCAGCMGCCGCGGTAA; 806R: GGACTACHVGGGTWTCTAAT),
was used to amplify the V4 region of the 16S rRNA gene.17 The PCR
products were then checked for size and speciﬁcity by agarose gel
electrophoresis. The amplicons were pooled in equimolar amounts
and sequenced with an Ion PGM Hi-Q 400 Sequencing Kit. The
sequences obtained were ﬁltered to remove low-quality and
polyclonal sequences, and the adapter sequences were trimmed.
The ﬁltered data for each sample (>50 000 sequenced reads) were
used to construct operational taxonomic units. The resulting
clusters of sequences were used for accurate taxonomic assign-
ment to the genus level and the number of sequences in each genus
was calculated using the 16S rDNA analysis pipeline.2.4. Sanger sequencing and quantitative PCR
For Sanger sequencing, a PCR assay was used to amplify the 16S
rRNA gene in the 19 GM samples. The mixture contained PCR mix
buffer, forward primer, reverse primer, and the genomic DNA
template in a volume of 40 ml. Hot start PCR was initiated by
incubation for 3 min at 95 8C, and ended with a 5-min extension at
72 8C, with 40 cycles of denaturation at 95 8C for 15 s, annealing at
60 8C for 25 s, and extension at 72 8C for 50 s. The PCR products
were sent for sequencing. The relevant sequences and the expected
sizes of the amplicons are shown in Table 1.
A qPCR assay was developed to speciﬁcally detect the species C.
kroppenstedtii, which consisted of genomic DNA, Takara PCR
Master Mix buffer (TAKARA Biotechnology (Dalian) Co., Ltd.,
Dalian), forward primer, reverse primer, and probe, in a volume of
40 ml. The PCR cycling conditions were as follows: 1 cycle at 50 8C
for 2 min, followed by one cycle at 95 8C for 10 min and 40 cycles at
92 8C for 15 s, 58 8C for 20 s, and 65 8C for 45 s. The quantiﬁcation
cycle (Cq) values were measured at a ﬁxed ﬂuorescence threshold.
Samples with Cq > 40 were considered negative. All analyses were
performed on an ABI 7500 Real-Time PCR System (Applied
Biosystems).
2.5. Bacterial culture
Breast pus was aspirated with a sterile syringe and cultured on
5% sheep blood agar after the plate was streaked. The inoculated
plates were incubated at 35 8C in 5% CO2 for 18–24 h. Isolates
retrievable from stock cultures were identiﬁed by their colony
morphology, Gram staining, biochemical tests, and the RapID CB
Plus System (Remel Inc., USA), as recommended by the manufac-
turer.18
3. Results
3.1. Bacterial proﬁles in breast pus
The taxonomic assignment of the sequences determined
classiﬁed them into diverse genera. The top 10 genera were
Bacteroides, Blautia, Corynebacterium, Dialister, Escherichia–Shi-
gella, incertae sedis, Lactobacillus, Prevotella, Staphylococcus, and
Streptococcus. For convenience, other cultured and uncultured
bacteria were combined into ‘others’. As controls, the DNA was
extracted from three pus samples obtained from patients with acute
lactating mastitis associated with known Staphylococcus and
Streptococcus infections, conﬁrmed by bacterial culture. These
DNA samples were used in the metagenomic analysis, together with
the DNA of the 19 specimens from patients with GM. As expected,
the genera Staphylococcus (89.1%, 96.6%) and Streptococcus (97.2%)
clearly predominated in the three control samples (SA1, SA2, and
SR1) (Fig. 1). These results indicate that the system is suitable for the
analysis of additional unknown samples. In general, the bacterial
proﬁles of the GM subjects differed clearly from those of the
controls. Samples GM8 and GM16 had relatively high abundances of
Fig. 1. Bar graph of the taxonomic proﬁles of the breast pus microbiota at the genus level. A metagenomic analysis compared the relative abundances of bacterial taxa in
19 patients with granulomatous mastitis and three controls suffering acute lactating mastitis (SA1, SA2, and SR1). Each bar represents a subject. The top 10 taxa names are
shown on the right.
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infected with Corynebacterium and Streptococcus.
3.2. Presence of Corynebacterium in GM
Previous studies using culture or conventional PCR assays have
demonstrated that Corynebacterium is commonly detected in GM
subjects. Therefore, focus was placed on Corynebacterium in the
present study. The percentages of Corynebacterium in the 19 GM
patients are shown in Table 2. Although the abundance of this
taxon showed inter-individual variability, the overall bacterial
communities were dominated by Corynebacterium in at least
seven subjects.
3.3. Predominance of C. kroppenstedtii in GM
To identify Corynebacterium at the species level, speciﬁc
primers were designed for further analysis. First, PCR was used andTable 2




Sanger sequencing qPCR for
C. kroppenstedtii
GM1 58.95 C. kroppenstedtii Positive
GM2 55.42 Sequencing failure Positive
GM3 43.52 C. kroppenstedtii Positive
GM4 21.87 C. kroppenstedtii Positive
GM5 20.97 Corynebacterium Negative
GM6 17.96 C. kroppenstedtii Positive
GM7 17.35 C. kroppenstedtii Positive
GM8 7.62 Non-Corynebacterium Negative
GM9 7.39 C. kroppenstedtii Positive
GM10 7.32 C. kroppenstedtii Positive
GM11 6.09 Non-Corynebacterium Negative
GM12 5.44 Corynebacterium Negative
GM13 4.28 C. kroppenstedtii Positive
GM14 4.04 Sequencing failure Positive
GM15 3.64 Non-Corynebacterium Negative
GM16 2.27 Non-Corynebacterium Negative
GM17 2.07 C. kroppenstedtii Negative
GM18 1.16 C. kroppenstedtii Negative
GM19 1.10 C. kroppenstedtii Positive
qPCR, quantitative PCR.the ampliﬁed fragments were examined by agarose gel electro-
phoresis. The expected PCR products were then subjected to
Sanger sequencing and a BLAST search before assignment. The C.
kroppenstedtii-speciﬁc qPCR assay was also performed. The data
showed the presence of C. kroppenstedtii in 11 of the 19 patients,
which was accurately identiﬁed with two different molecular
techniques, indicating the predominance of C. kroppenstedtii
infection in GM. Of these 11 subjects, the samples of nine were
shown to be positive for C. kroppenstedtii by both Sanger
sequencing and qPCR. Samples GM2 and GM14 could not be
speciﬁcally identiﬁed with Sanger sequencing because of sequenc-
ing failure/problems. In another discrepancy, Sanger sequencing
conﬁrmed that samples GM17 and GM18 were infected with C.
kroppenstedtii, but they were negative in the speciﬁc qPCR assay
(Table 2).
4. Discussion
The successful culture of fastidious or anaerobic organisms
remains challenging and it is estimated that approximately half of
all bacteria are uncultivable. Corynebacterium was not cultured
from the pus samples in this study. It is likely that the incubation
period (18–24 h) used for the cultures was too short, and longer
incubation for 72–96 h may be more successful. The delay between
sampling and inoculation might also reduce the culture yield,
especially for fastidious bacteria like Corynebacterium. Notably,
previous studies have shown that media that contain Tween 80 are
critical for the culture of corynebacteria. This alternative is
currently being explored.
Metagenomics is a culture-independent approach that provides
a good way to assess the microbial makeup of a mixed sample. This
appears to be the ﬁrst study to have used this powerful technique
to characterize the bacterial communities and identify potential
microbial pathogens in GM. Because Corynebacterium is increas-
ingly recognized as a causative pathogen of GM, focus was placed
on this genus. Although the relative abundance of corynebacteria
varied signiﬁcantly, seven specimens (more than a third of
subjects) showed a predominance of Corynebacterium within
their whole microbiota.
Pus samples cannot be obtained from healthy women, thus
three age-matched women suffering from acute lactating mastitis,
who had known pathogen infections conﬁrmed by bacterial
H.-j. Yu et al. / International Journal of Infectious Diseases 53 (2016) 30–33 33culture, were included in the metagenomic analysis as controls . As
expected, the most abundant taxa in the controls were Staphylo-
coccus and Streptococcus. A recent study also assessed the
microbial signatures of breast tissue in samples obtained
intraoperatively using metagenomic sequencing. The authors
compared the microbial taxonomic proﬁles of healthy breast
tissue and breast tissues from women with benign disease or
invasive cancer at the genus level. The relative abundance of
Corynebacterium was less than 0.5%, a tiny and negligible
component of the microbiota in the human breast.19 Taken
together, these ﬁndings indicate that Corynebacterium is closely
associated with GM.
Of note, metagenomics only provides the relative abundances
of speciﬁc bacterial genera, and the taxonomic assignment of the
sequences obtained can only be determined accurately to the
genus level and not to the species level. In previous studies,
Corynebacterium, especially C. kroppenstedtii, was frequently
detected in specimens from GM patients and was thought to be
a particularly important agent in this condition. Once a diagnosis of
GM is made, most patients undergo a prolonged course of
treatment and often experience recurrence because there are no
published treatment protocols for this disease. A recent study
demonstrated that C. kroppenstedtii isolates were susceptible to
seven antibiotic classes, including rifampicin and vancomycin, but
resistant to the b-lactams. However, Corynebacterium tuberculos-
tearicum isolates were found to be multidrug-resistant.20 The
clinical outcomes of GM patients are closely related to the
antimicrobial treatment used and the precise identiﬁcation of the
Corynebacterium species. Therefore, a qPCR assay was developed in
this study for the quantitative detection of C. kroppenstedtii in
clinical samples. It is hoped that this will guide the management of
GM based on C. kroppenstedtii-speciﬁc qPCR results, instead of
bacterial cultures. The early identiﬁcation of C. kroppenstedtii
infection and the prompt initiation of combination antimicrobials
should beneﬁt these patients.
This study was retrospective and is therefore limited by the
inherent problem of collecting complete data. However, the
ﬁndings support the causative role of Corynebacterium, and in
particular C. kroppenstedtii, in the pathogenesis of GM. Their
presence in GM and their pathological roles warrant further
research. A prospective study of women with GM is in preparation
to more clearly deﬁne the importance of Corynebacterium species
in this disease, using targeted therapy in a clinical setting. It is
hoped that the selective use of antibiotics will signiﬁcantly
improve the progression and outcomes of GM.
In summary, the bacterial ﬂora of GM was investigated with
metagenomic proﬁling in this study. A predominance of Coryne-
bacterium, especially C. kroppenstedtii, was observed in GM,
indicating its involvement in this disease entity. A C. kroppen-
stedtii-speciﬁc qPCR assay was developed to guide selective
antibiotic therapy in future research. This study highlights therole of C. kroppenstedtii infection in GM and should contribute to its
optimal management.
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